Frans H.M. Corstens

12.5k total citations
244 papers, 9.6k citations indexed

About

Frans H.M. Corstens is a scholar working on Radiology, Nuclear Medicine and Imaging, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Frans H.M. Corstens has authored 244 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Radiology, Nuclear Medicine and Imaging, 80 papers in Surgery and 71 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Frans H.M. Corstens's work include Radiopharmaceutical Chemistry and Applications (99 papers), Orthopedic Infections and Treatments (60 papers) and Medical Imaging Techniques and Applications (46 papers). Frans H.M. Corstens is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (99 papers), Orthopedic Infections and Treatments (60 papers) and Medical Imaging Techniques and Applications (46 papers). Frans H.M. Corstens collaborates with scholars based in Netherlands, United States and United Kingdom. Frans H.M. Corstens's co-authors include Wim J.G. Oyen, Otto C. Boerman, J.W.M. van der Meer, Peter Laverman, Chantal P. Bleeker‐Rovers, E.T.M. Dams, Roland A. M. J. Claessens, Gert Storm, W C Buijs and Ingrid Dijkgraaf and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Frans H.M. Corstens

242 papers receiving 9.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frans H.M. Corstens Netherlands	53	4.0k	2.2k	2.1k	1.8k	1.5k	244	9.6k
Mukesh G. Harisinghani United States	51	2.5k 0.6×	936 0.4×	3.1k 1.5×	2.7k 1.5×	913 0.6×	271	8.5k
Douglas B. Cines United States	75	973 0.2×	3.3k 1.5×	5.6k 2.6×	2.9k 1.6×	1.1k 0.7×	357	22.8k
Steven K. Libutti United States	67	1.3k 0.3×	4.9k 2.3×	3.1k 1.5×	2.2k 1.2×	4.7k 3.1×	331	15.2k
Alberto Signore Italy	47	1.8k 0.5×	1.0k 0.5×	3.4k 1.6×	831 0.5×	1.3k 0.9×	288	8.1k
Otto C. Boerman Netherlands	75	8.8k 2.2×	6.2k 2.9×	2.9k 1.4×	3.6k 2.0×	5.7k 3.8×	494	22.0k
Jürgen K. Willmann United States	54	3.8k 0.9×	2.3k 1.0×	1.7k 0.8×	1.4k 0.8×	1.3k 0.8×	166	11.0k
Gooitzen M. van Dam Netherlands	48	1.7k 0.4×	1.5k 0.7×	2.3k 1.1×	2.2k 1.2×	1.5k 1.0×	169	8.8k
Mathew L. Thakur United States	41	2.2k 0.6×	1.5k 0.7×	1.3k 0.6×	999 0.6×	1.1k 0.7×	227	6.0k
J Wittenberg United States	52	2.5k 0.6×	466 0.2×	3.3k 1.5×	1.9k 1.1×	1.3k 0.8×	168	8.3k
Zaverio M. Ruggeri United States	87	1.0k 0.3×	3.3k 1.5×	3.9k 1.8×	4.2k 2.3×	1.2k 0.8×	264	24.0k

Countries citing papers authored by Frans H.M. Corstens

Since Specialization

Citations

This map shows the geographic impact of Frans H.M. Corstens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frans H.M. Corstens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frans H.M. Corstens more than expected).

Fields of papers citing papers by Frans H.M. Corstens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frans H.M. Corstens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frans H.M. Corstens. The network helps show where Frans H.M. Corstens may publish in the future.

Co-authorship network of co-authors of Frans H.M. Corstens

This figure shows the co-authorship network connecting the top 25 collaborators of Frans H.M. Corstens. A scholar is included among the top collaborators of Frans H.M. Corstens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frans H.M. Corstens. Frans H.M. Corstens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Boerman, Otto C., et al.. (2006). Targeting of Biliary Cancer with Radiolabeled Chimeric Monoclonal Antibody CG250. Cancer Biotherapy and Radiopharmaceuticals. 21(3). 263–268. 6 indexed citations

2.

Kok, Peter J.M.J., et al.. (2005). Biodistribution and Imaging of FDG in Rats with LS174T Carcinoma Xenografts and Focal Escherichia coli Infection. Cancer Biotherapy and Radiopharmaceuticals. 20(3). 310–315. 9 indexed citations

3.

Rennen, Huub J J M, Chantal P. Bleeker‐Rovers, Cathelijne Frielink, et al.. (2004). 99m Tc-Labeled Interleukin-8 for Scintigraphic Detection of Pulmonary Infections. CHEST Journal. 126(6). 1954–1961. 15 indexed citations

4.

Janssen, Marcel, Cathelijne Frielink, Ingrid Dijkgraaf, et al.. (2004). Improved Tumor Targeting of Radiolabeled RGD Peptides Using Rapid Dose Fractionation. Cancer Biotherapy and Radiopharmaceuticals. 19(4). 399–404. 38 indexed citations

5.

Brouwers, Adrienne H., Peter Mulders, Egbert Oosterwijk, et al.. (2004). Pharmacokinetics and Tumor Targeting of 131I-Labeled F(ab9)2 Fragments of the Chimeric Monoclonal Antibody G250: Preclinical and Clinical Pilot Studies. Cancer Biotherapy and Radiopharmaceuticals. 19(4). 466–477. 21 indexed citations

6.

Geus‐Oei, Lioe‐Fee de, et al.. (2004). Tracers to Monitor the Response to Chemotherapy: In Vitro Screening of Four Radiopharmaceuticals. Cancer Biotherapy and Radiopharmaceuticals. 19(4). 457–465. 2 indexed citations

7.

Brouwers, Adrienne H., Peter F.A. Mulders, Egbert Oosterwijk, et al.. (2004). Pharmacokinetics and Tumor Targeting of <SUP>131</SUP>I-Labeled F(ab')<SUB>2</SUB> Fragments of the Chimeric Monoclonal Antibody G250: Preclinical and Clinical Pilot Studies. Cancer Biotherapy and Radiopharmaceuticals. 19(4). 466–477. 17 indexed citations

8.

Janssen, Marcel, Cathelijne Frielink, Ingrid Dijkgraaf, et al.. (2004). Improved Tumor Targeting of Radiolabeled RGD Peptides Using Rapid Dose Fractionation. Cancer Biotherapy and Radiopharmaceuticals. 19(4). 399–404. 20 indexed citations

9.

Brouwers, Adrienne H., Iris Verel, Gerard W.M. Visser, et al.. (2004). PET Radioimmunoscintigraphy of Renal Cell Cancer Using ⁸⁹ Zr-Labeled cG250 Monoclonal Antibody in Nude Rats. Cancer Biotherapy and Radiopharmaceuticals. 19(2). 155–163. 49 indexed citations

10.

Postema, Ernst J., Cathelijne Frielink, Wim J.G. Oyen, et al.. (2003). Biodistribution of ¹³¹ I-, ¹⁸⁶ Re-, ¹⁷⁷ Lu-, and ⁸⁸ Y-Labeled hLL2 (Epratuzumab) in Nude Mice with CD22-Positive Lymphoma. Cancer Biotherapy and Radiopharmaceuticals. 18(4). 525–533. 22 indexed citations

11.

Brouwers, Adrienne H., Cathelijne Frielink, Egbert Oosterwijk, et al.. (2003). Interferons Can Upregulate the Expression of the Tumor Associated Antigen G250-MN/CA IX, a Potential Target for (Radio)Immunotherapy of Renal Cell Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 18(4). 539–547. 13 indexed citations

12.

Janssen, Marcel, Wim J.G. Oyen, Leon F.A.G. Massuger, et al.. (2002). Comparison of a Monomeric and Dimeric Radiolabeled RGD-Peptide for Tumor Targeting. Cancer Biotherapy and Radiopharmaceuticals. 17(6). 641–646. 154 indexed citations

13.

Boerman, Otto C., E.T.M. Dams, Wim J.G. Oyen, Frans H.M. Corstens, & G. Storm. (2001). Radiopharmaceuticals for scintigraphic imaging of infection and inflammation. Inflammation Research. 50(2). 55–64. 36 indexed citations

14.

Boerman, Otto C., Wim J.G. Oyen, & Frans H.M. Corstens. (2000). Pretargeted Radioimmunotherapy of Non-Hodgkin's Lymphoma: Best of Both Worlds?. Cancer Biotherapy and Radiopharmaceuticals. 15(1). 1–5. 1 indexed citations

15.

Oyen, Wim J.G., Otto C. Boerman, & Frans H.M. Corstens. (2000). Imaging acute appendicitis: an opportunity for nuclear medicine in the surgical emergency room.. Radboud Repository (Radboud University). 41(3). 456–8. 8 indexed citations

16.

Oyen, Wim J.G., Otto C. Boerman, G. Storm, et al.. (1996). Labelled StealthR liposomes in experimental infection. Nuclear Medicine Communications. 17(9). 742–748. 26 indexed citations

17.

Linden, Josje van der, et al.. (1994). Early detection of post-transplant pancreatic graft dysfunction with technetium-99m-HMPAO scintigraphy.. PubMed. 35(9). 1488–90. 3 indexed citations

18.

Massuger, Leon F.A.G., Roland A. M. J. Claessens, Koon Y. Pak, et al.. (1991). Tissue distribution of technetium 99m indium 111 labelled and iodine 123 ov tl 3 fab in ovarian carcinoma bearing nude mice. Nuclear Medicine and Biology. 18(1). 77–84. 4 indexed citations

19.

Festen, Jan, et al.. (1990). No effect of oral high frequency oscillation combined with forced expiration manoeuvres on tracheobronchial clearance in chronic bronchitis. European Respiratory Journal. 3(1). 14–18. 16 indexed citations

20.

Festen, Jan, et al.. (1988). The Effect of Positive Expiratory Pressure versus Forced Expiration Technique on Tracheobronchial Clearance in Chronic Bronchitics. Scandinavian Journal of Gastroenterology. 23(sup143). 114–118. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact